Technical Analysis for VSTM - Verastem, Inc.
|Grade||Last Price||% Change||Price Change|
VSTM closed up 2.37 percent on Friday, January 18, 2019, on 88 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
|See historical VSTM trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Stochastic Reached Oversold||Weakness||0.00%|
|Jan 18||Oversold Stochastic||Weakness||0.00%|
|Jan 17||NR7||Range Contraction||2.37%|
|Jan 17||Doji - Bullish?||Reversal||2.37%|
|Jan 16||20 DMA Resistance||Bearish||2.37%|
|Jan 15||Doji - Bullish?||Reversal||0.58%|
|Jan 14||Fell Below 20 DMA||Bearish||1.47%|
|Jan 14||Wide Bands||Range Expansion||1.47%|
|Jan 14||Down 3 Days in a Row||Weakness||1.47%|
|Jan 11||Stochastic Sell Signal||Bearish||-6.99%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib testing in ovarian cancer, as well as developing for the treatment of mesothelioma and breast cancer. It is also developing FAK inhibitor VS-4718 and PI3K/mTOR inhibitor VS-5584 in patients with advanced cancers. The company's product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. Verastem, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more VSTM news...
|52 Week High||10.35|
|52 Week Low||2.77|
|200-Day Moving Average||6.04|
|50-Day Moving Average||4.323|
|20-Day Moving Average||3.5715|
|10-Day Moving Average||3.695|
|Average True Range||0.284|
|Chandelier Exit (Long, 3 ATRs )||3.398|
|Chandelier Exit (Short, 3 ATRs )||3.992|
|Upper Bollinger Band||4.1022|
|Lower Bollinger Band||3.0408|
|Percent B (%b)||0.39|
|MACD Signal Line||-0.2407|
|Market Cap||127.99 Million|
|Num Shares||37 Million|
|Price-to-Earnings (P/E) Ratio||-2.79|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||3.79|
|Resistance 3 (R3)||3.76||3.62||3.74|
|Resistance 2 (R2)||3.62||3.54||3.64||3.72|
|Resistance 1 (R1)||3.54||3.48||3.58||3.57||3.70|
|Support 1 (S1)||3.32||3.32||3.36||3.35||3.22|
|Support 2 (S2)||3.18||3.26||3.20||3.20|
|Support 3 (S3)||3.10||3.18||3.19|
|Support 4 (S4)||3.13|